Cargando…
What is the impact of regulatory guidance and expiry of drug patents on dementia drug prescriptions in England? A trend analysis in the Clinical Practice Research Datalink
BACKGROUND: Drugs for dementia have been available in England since 1997. Since their launch, there have been several changes to national guidelines and initiatives that may have influenced prescribing. These include changes in National Institute for Health and Care Excellence (NICE) guidance, sever...
Autores principales: | Walker, Venexia M., Davies, Neil M., Kehoe, Patrick G., Martin, Richard M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5975499/ https://www.ncbi.nlm.nih.gov/pubmed/29843807 http://dx.doi.org/10.1186/s13195-018-0379-6 |
Ejemplares similares
-
The Impact of Patent Expiry on Drug Prices: A Systematic Literature Review
por: Vondeling, Gerard T., et al.
Publicado: (2018) -
The impact of patent expiry on drug prices: insights from the Dutch market
por: van der Schans, Simon, et al.
Publicado: (2020) -
Can commonly prescribed drugs be repurposed for the prevention or treatment of Alzheimer's and other neurodegenerative diseases? Protocol for an observational cohort study in the UK Clinical Practice Research Datalink
por: Walker, Venexia M, et al.
Publicado: (2016) -
Comparison of Antihypertensive Drug Classes for Dementia Prevention
por: Walker, Venexia M., et al.
Publicado: (2020) -
Drug expiry debate: the myth and the reality
por: Gikonyo, Dan, et al.
Publicado: (2019)